Stem Cells Canadian Perspective
|
|
- Coral Goodwin
- 6 years ago
- Views:
Transcription
1 Stem Cells Canadian Perspective John Laffey Critical Illness and Injury Research Centre, Keenan Research Centre, St Michael s Hospital. Departments of Anesthesia, Physiology and Interdepartmental Division of Critical Care Medicine, University of Toronto.
2 Conflict of Interest Tissue Regeneration Therapeutics, Toronto, Canada Orbsen Therapeutics Ltd, Galway, Ireland CommenceBio, California, USA Council member, Ontario Institute of Regenerative Medicine
3 Stem Cells A Canadian discovery
4 What are STEM CELLS? Resident Lung Stem Cells Embryonic Stem Cells Induced Pluripotent Stem Cells Endothelial Progenitor Cells Mesenchymal Stromal Cells Mature cells Stem cell Proliferation Differentiation Griffiths M et al. Lancet 2005;366:245
5 Bone Marrow Stem/Stromal Cells
6 Advantages of MSCs
7 Stem Cell Therapies focusing on lung Repair??
8 Anaesthetize Intubate IV MSC Therapy Anaesthetize 48hrs Compliance ed 50% Assessment of Recovery from ARDS High Stretch Ventilation Recover and extubate
9 Curley et al, Thorax 2012 MSCs enhance injury resolution following VILI
10 Hayes, Masterson et al, Anesthesiology 2014
11 Gupta, Krasnodembskaya et al, Thorax 2012
12 Survival hmscs (10-20 million/kg) Vehicle/Fibroblast Time (Hours) Devaney et al, Thorax 2015
13 Devaney et al, Thorax 2015
14 Umbilical cord MSCs Ease of accessibility Absence of risk for the donor Absence of pain for donor Consistency in terms of age at collection
15 Sham E.Coli + Vehicle E.Coli + UC-MSC
16 How do MSCs work?
17 Curley et al, Anesthesiology 2013
18 Krasnodembskaya et al, Stem Cells 2010
19
20
21
22 Devaney et al, Thorax 2015
23 MSCs enhance Macrophage Phagocytosis of Bacteria BACTERIA INFECTION UNTREATED MSC TREATED
24 MSCs Key mechanisms of Action Laffey & Matthay AJRCCM 2017
25 hmscs for ARDS where are we now?
26
27
28
29 2015 by American Society of Hematology Blood 2015;126:2220
30 Stem Cells for ARDS Challenges Understanding mechanisms of action Scaling MSC production for Clinical Trials Cryopreservation versus Fresh Cells Batch to batch variability Potency assays Optimal cell source Cost of large scale Clinical Trials for cell therapies Need for flexible approaches Turning critical care doctors into transplant physicians Laffey and Matthay, AJRCCM 2017
31 Canadian..contributions to health research and medicine. Two stand out as landmarks: the discovery of insulin in the 1920s and the discovery of stem cells in the 1960s. Canada founded the entire field of stem-cell science.discovering neural stem cells, skin stem cells and cancer stem cells. Canada does this for a dime.the all in investment in stem-cell research in Canada..is about $75-million [2012 Figures]. Funding still seriously lags behind California, which, with roughly the same population as Canada, has committed $3-billion over 10 years for stem-cell research.
32 Cell therapy trials in Ontario Brain and/or nerves Phase II using MSCs for Multiple Sclerosis: Toronto* Phase III using diabetes drug to stimulate brain repair for malignant brain tumours: Toronto* trials 11 partners Heart Phase II using genetically modified stem cells following heart attack: Ottawa and Toronto* Phase II using MSCs for advanced heart failure with left ventricular assist device: Toronto* Blood Phase I using immune cells for blood cancer relapse after bone marrow transplantation: Toronto* Joints Phase I-II using stem cells midto late-stage knee osteoarthritis; Toronto* 3 Ontario cities 655+ patients Billions of stem cells Spine Phase I/II using neural stem cells for spinal cord trauma: Toronto* Critical care Phase I using MSCs for septic shock: Ottawa* Digestive system Phase III using MSCs to induce remission of Crohn s disease: London and Toronto * OIRM researchers leading trial
33 Hematopoietic stem cell transplantation First Proof of efficacy (in AML) Ongoing Discoveries e.g. MSCs for GVHD / First Animal studies First Human studies Human Allogenic BM Transplant Proof of efficacy in CML
34 Stem Cells A Canadian Perspective Stem cells offer considerable potential for Critical Illnesses Pre-clinical studies highly encouraging MSCs now in early phase Clinical Studies for ARDS Clinical Translational pathway likely to be lengthy and there will be setbacks... Twin-track strategy of pre-clinical research and early phase clinical translational studies in progress Canada s role in realizing clinical potential of stem cells World leading Preclinical/Discovery science CISS-1 Study a major step forward in Sepsis Laffey and Matthay, AJRCCM 2017
35 Acknowledgements Gerard Curley Mirjana Jerkic Stephane Gagnon Claire Masterson Allen Volchuk Grace Hogan Lindsey Ormsher Linda Garces Haibo Zhang Wolfgang Kuebler Sergio Grinstein Timothy O Brien
At the conclusion of this lesson you should be able to:
Learning Objectives At the conclusion of this lesson you should be able to: Understand the key terms and definitions regarding stem cells Differentiate between the adult and embryonic stem cells Differentiate
More informationDes cellules-souches dans le poumon : pourquoi faire?
Des cellules-souches dans le poumon : pourquoi faire? Karl-Heinz Krause Dept. of Pathology and Immunology, Medical Faculty Dept. of Genetic and Laboratory Medicine, University Hospitals Geneva, Switzerland
More informationPACT. PACT Program. Production Assistance for Cellular Therapies
PACT Production Assistance for Cellular Therapies University of Wisconsin PACT-sponsored Workshop Developing Cellular Therapies: From Preclinical Safety To Clinical Evaluation Tuesday, April 09, 2013 Robert
More informationFrom Stem Cell to Any Cell
sciencenewsforkids.org http://www.sciencenewsforkids.org/2005/10/from-stem-cell-to-any-cell-2/ From Stem Cell to Any Cell By Emily Sohn / October 11, 2005 For maybe a day, about 9 months before you were
More informationThe New News in Stem Cell Research Andrés Bratt-Leal, PhD 12/1/2017
The New News in Stem Cell Research Andrés Bratt-Leal, PhD 12/1/2017 Cell Therapy and Parkinson s Disease Very specific neural degeneration >50% of DA neurons are gone by diagnosis 1 million in the USA,
More informationClinical Applications of Mesenchymal Stromal Cells
Clinical Applications of Mesenchymal Stromal Cells John Girdlestone PhD Stem Cells and Immunotherapies NHS Blood and Transplant, Oxford John Radcliffe Hospital Mesenchymal Stromal Cells (MSC) Fibroblastic,
More informationStem cells and motor neurone disease
Stem cells and motor neurone disease F Stem cell research has fuelled hope of a treatment for a variety of conditions. This information sheet explains what these cells are and includes details of the current
More informationPatient Handbook on Stem Cell Therapies
Patient Handbook on Stem Cell Therapies WWW.ISSCR.ORG WWW.CLOSERLOOKATSTEMCELLS.ORG Patient Handbook on Stem Cell Therapies Introduction We have all heard about the extraordinary promise that stem cell
More informationPRIME-XV Cell Therapy Products by
PRIME-XV Cell Therapy Products by Product List 2017 TRINOVA BIOCHEM now distributes the PRIME-XV Cell Therapy line by Irvine Scientific in Germany, Austria and Switzerland. Irvine Scientific is a worldwide
More informationNEXT GENERATION ECM-BASED ALLOGRAFT TECHNOLOGY:
NEXT GENERATION ECM-BASED ALLOGRAFT TECHNOLOGY: Potent biological scaffolds strategically control stem cell fate and function, allowing our allografts to harness the regenerative potential of patient s
More informationWhat Are Stem Cells? Where Are These Stem Cells?
While stem cell therapies may seem to have appeared overnight, they have been practiced for some time prior to the recent burst in new applications and stem cell sources. The most recent developments in
More informationProduction Assistance for Cellular Therapies PACT
Production Assistance for Cellular Therapies PACT Traci Heath Mondoro, PhD NHLBI Bethesda, Maryland Renewed PACT Program Renewed January 15, 2010 Scope and size expanded Cell Processing Facilities (CPFs)
More informationStem Cells: A Primer National Institutes of Health
Stem Cells: A Primer National Institutes of Health I. INTRODUCTION Research on stem cells is advancing knowledge about how an organism develops from a single cell and how healthy cells replace damaged
More informationBIOLOGIC MEDICATIONS IN THE TREATMENT OF IBD. crohnsandcolitis.ca
BIOLOGIC MEDICATIONS IN THE TREATMENT OF IBD crohnsandcolitis.ca BIOLOGIC MEDICATIONS IN THE TREATMENT OF IBD INFLAMMATION AND IMMUNITY IN CROHN S AND COLITIS Inflammation is the body s normal and natural
More informationStem Cell Principle -
Effective Date: 31.10.2017 Doc ID: 20290214 Version: 1.0 Status: Approved Planned Effective Date: 31-Oct-2017 00:00 CET (Server Date) Stem Cell Principle - Rationale Research on human stem cells and their
More informationSpecial Report. medicine? Peter Marks, M.D., Ph.D., and Scott Gottlieb, M.D.
The new england journal of medicine Special Report Balancing Safety and Innovation for Cell-Based Regenerative Medicine Peter Marks, M.D., Ph.D., and Scott Gottlieb, M.D. Regenerative medicine is a field
More informationRegeneration of spinal cord injury (SCI) : What we know so far. By: Kendra Michaud
Regeneration of spinal cord injury (SCI) : What we know so far By: Kendra Michaud INTRODUCTION BACKGROUND/IMPACT Neerumalla, Dr. Ravali. Spinal Cord Injury - Causes, Symptoms, Diagnosis, Treatment & Prevention.
More informationStem Cells: Ethics and Oversight May 24, Sidney H. Golub, Ph.D. Interim Director Sue & Bill Gross Stem Cell Research Center
Stem Cells: Ethics and Oversight May 24, 2017 Sidney H. Golub, Ph.D. Interim Director Sue & Bill Gross Stem Cell Research Center Nobel Laureates 2012 John Gurdon Shinya Yamanaka Pluripotent Stem Cell PLURIPOTENT
More informationStem Cells for the Future Treatment of Parkinson's Disease
Home Stem Cell Basics Stem Cell Basics I. Introduction II. III. IV. What are the unique properties of all stem cells? What are embryonic stem cells? What are adult stem cells? V. What are the similarities
More informationClip 1: Hip dysplasia Clip 2: Vet-Stem s Dr. Harman
Stem Cells Many breeds of large dogs are affected by hip dysplasia. This degenerative disease affects their hind legs, hindering mobility. Watch as scientists at Vet-Stem explain how stem cells are used
More informationStephen Strom (Cell Transplantation and Regenerative Medicine, KI) Stem Cell Therapy of Liver Disease
Final Programme Tuesday 13 th October Location: HERM Seminar Room, NOVUM, 4 th Floor (entrance through HERM) 9.15-9.20 Welcome and Introduction to the Sessions Chair: Hong Qian (HERM, KI) 9.20-10.15 Hong
More informationInsight to Gene Techno Science Co.,Ltd
Unlimited drug discovery from the beginning Ticker symbol: 4584 Insight to Gene Techno Science Co.,Ltd November 2017 2 Corporate Overview Chief Executive Founded March 2001 Masaharu Tani, President Listed
More informationREIMAGINING DRUG DEVELOPMENT:
Biology Reconstructed REIMAGINING DRUG DEVELOPMENT: Accurate Disease Modeling To Drive Successful Therapies Julia Kirshner, CEO julia@zpredicta.com 1 SUCCESS RATES OF DRUG DEVELOPMENT ARE LOW, " PARTICULARLY
More informationPLTW Biomedical Science Medical Interventions Course Outline
Follow the fictitious Smith family as you learn about the prevention, diagnosis, and treatment of disease. Play the role of biomedical professionals to analyze case information and diagnose and treat your
More informationTHE PATH TO PRECISION MEDICINE IN MULTIPLE MYELOMA. themmrf.org
THE PATH TO PRECISION MEDICINE IN MULTIPLE MYELOMA themmrf.org ABOUT THE MULTIPLE MYELOMA RESEARCH FOUNDATION The Multiple Myeloma Research Foundation (MMRF) was established in 1998 by identical twin sisters
More informationAn Taoiseach Opens New Research Centres to Benefit Frontline Patient Care
An Taoiseach Opens New Research Centres to Benefit Frontline Patient Care The clinical translational research facility will be a significant development for health care and medical technology sector in
More informationMyeloma Bone Disease Current and Future Treatment. A Publication of The Bone and Cancer Foundation
Myeloma Bone Disease Current and Future Treatment A Publication of The Bone and Cancer Foundation What Is Multiple Myeloma? Multiple Myeloma is a cancer that results from a malignant change in a particular
More informationSupplemental Information. Selling Stem Cells in the USA: Assessing the Direct-to-Consumer Industry. Leigh Turner and Paul Knoepfler
Cell Stem Cell, Volume 19 Supplemental Information Selling Stem Cells in the USA: Assessing the Direct-to-Consumer Industry Leigh Turner and Paul Knoepfler Supplemental Information Search approach We used
More informationShould Embryonic Stem Cell Research be Permitted to Continue? Over the past few years a debate has been going on over the moral implications of
Courtesy of Christopher Waits. Used with permission. Waits 1 Should Embryonic Stem Cell Research be Permitted to Continue? Over the past few years a debate has been going on over the moral implications
More informationBlue Marble University Biology Course Handbook
Blue Marble University Biology Course Handbook A Summary of Course Descriptions Courses and Content Subject to Change Without Notice BlueMarbleUniversity.com Info@bluemarbleuniversity.com Stem Cell Biology
More informationHCT/P Regulation vs 361 Products
HCT/P Regulation - 351 vs 361 Products Presented by: Paul Gadiock February 15, 2017 Arent Fox LLP Washington, DC New York, NY Los Angeles, CA San Francisco, CA 1 Presentation Overview Introduction Public
More informationRecent advances in tissue-engineered corneal regeneration
4 Special Issue: Positioning of Tissue Engineering in Regenerative Medicine Review Article Recent advances in tissue-engineered corneal regeneration Eun Young Kim 1), Jeong Eun Song 1), Chan Hum Park 2),
More informationThe 3Rs: are Human Stem Cells and Organs on Chip alternatives?
The 3Rs: are Human Stem Cells and Organs on Chip alternatives? Towards precision medicine in future healthcare Christine Mummery Leiden University Medical Centre University Twente hdmt Three kinds of human
More informationleading the way in research & development
leading the way in research & development people. passion. possibilities. ABBVIE 2 immunology AbbVie Immunology has a demonstrated record of success in identifying and developing both small molecule and
More informationScientists have successfully used stem cells to reverse this paralysis. Magnification 0.02
1 The photograph below shows an X-ray of a dachshund. The dachshund is a breed of dog that is at higher risk of paralysis due to spinal injury. Scientists have successfully used stem cells to reverse this
More informationSTEM CELLS. An Interactive Qualifying Project Report. Submitted to the Faculty of WORCESTER POLYTECHNIC INSTITUTE
IQP-43-DSA-2135 IQP-43-DSA-8130 STEM CELLS An Interactive Qualifying Project Report Submitted to the Faculty of WORCESTER POLYTECHNIC INSTITUTE In partial fulfillment of the requirements for the Degree
More informationStem Cell Services. Driving Innovation for Stem Cell Researchers
Driving Innovation for Stem Cell Researchers Stem Cell Services Partner with us and have access to the most advanced and comprehensive stem cell services available today. 675 W. Kendall St. Cambridge,
More informationStem cells in regenerative medicine: introduction
Published Online May 11, 2011 Stem cells in regenerative medicine: introduction Dusko Ilic 1, and Julia M. Polak 2* 1 Kings College London School of Medicine, Division of Women s Health, Assisted Conception
More informationThree Methods for Phase I/II Clinical Trials, with Application to Allogeneic
Three Methods for Phase I/II Clinical Trials, with Application to Allogeneic Stem Cell Transplantation Peter F. Thall, PhD Biostatistics Department M.D. Anderson Cancer Center Workshop on Clinical Trial
More informationEMBRYONIC STEM CELL RESEARCH: ALTERNATIVE METHODS & ALZHEIMER S DISEASE
EMBRYONIC STEM CELL RESEARCH: ALTERNATIVE METHODS & ALZHEIMER S DISEASE BY KHYATI PATEL Word count: Approx 2300 Grade awarded June 2006: PASS WITH DISTINCTION RESEARCH PAPER BASED ON PATHOLOGY LECTURES
More informationSTEM CELLS IN NEUROLOGY ISABELLE COCHRANE MERIT
STEM CELLS IN NEUROLOGY BY ISABELLE COCHRANE MERIT RESEARCH PAPER BASED ON PATHOLOGY LECTURES AT MEDLINK 2011 1 Abstract Ever since their discovery, stem cells have been heralded as the ultimate cure to
More informationStem cell dialogue: key findings, conclusions and recommendations. Dr Darren Bhattachary, Director BMRB
Stem cell dialogue: key findings, conclusions and recommendations Dr Darren Bhattachary, Director BMRB Objectives Engage the public and stakeholders on stem cells: policy development Views and concerns
More information#SIS25th. 25th Annual Meeting Slides
25th Annual Meeting Slides Stem Cell for Spine Care - From dish to disc Wenchun Qu, MD, PhD Mayo Clinic Rochester Disclosures ØConsultant, DePuy Synthes ØBoard of Directors, American Academy of Regenerative
More informationStem Cells. Part 1: What is a Stem Cell? STO Stem cells are unspecialized. What does this mean?
STO-120 Stem Cells Part 1: What is a Stem Cell? Stem cells differ from other kinds of cells in the body. When a stem cell divides by mitosis, each new cell has the potential to either remain a stem cell
More informationImmunogenicity of Stem Cells in Therapeutic Applications. MDPB-Registry meeting nov 25th Stem cell immunogenicity in therapeutic applications
Immunogenicity of Stem Cells in Therapeutic Applications MDPB-Registry meeting nov 25th 2016 Stem cell immunogenicity in therapeutic applications Has it been underestimated? Transplantation of any type
More informationInhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration. JournalClub Emilie Hrdliczka
Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration JournalClub 14.12.2015 Emilie Hrdliczka Facts Author: Yongyou Zhang Department of Medicine, Case Western Reserve
More informationMyeloma treatment algorithm 1999
Outlook for myeloma patients has improved Treatment for relapsed and/or refractory myeloma Dr Guy Pratt Consultant Haematologist, Heart of England NHS Foundation Trust Senior Lecturer, University of Birmingham
More informationEuropean Regenerative Medicine Firms & Their Strategic Approaches. Michael Morrison University of York
European Regenerative Medicine Firms & Their Strategic Approaches Michael Morrison University of York OVERVIEW Creating the European RM Universe of firms Characterizing the European RM Universe Strategic
More informationStem Cells and Regenerative Medicine
Q 0 Stem Cells and Regenerative Medicine Technologies and capabilities to add value to your company Differentiation HA-PPS for cartilage Parallel culture optimisation Stem Cell Therapies Fetal EPCs and
More informationUpdates on global movement in regulation of Advanced Therapeutics
DISCLAIMER : The contents of this presentation represent the view of this presenter only, and do not represent the views and/or policies of the PMDA Updates on global movement in regulation of Advanced
More informationThe Lancet Publishes Results from the Landmark Phase III Rivaroxaban Study RECORD2
News Release Bayer HealthCare AG Corporate Communications 51368 Leverkusen Germany Phone +49 214 30 1 www.news.bayer.com Venous Blood Clot Prevention after Hip Replacement Surgery: The Lancet Publishes
More informationRecent Progress in ips Cell Research and Application
Recent Progress in ips Cell Research and Application Shinya Yamanaka, M.D., Ph.D. Center for ips Cell Research and Application (CiRA), Kyoto University, Japan Takeda - CiRA Joint Program, Shonan, Japan
More informationIntroduction This is an exam style question on stem cells that might be useful towards the end of the topic.
Teacher Notes Introduction This is an exam style question on stem cells that might be useful towards the end of the topic. Suggested mark scheme (a) (i) a non-specialised cell any 1 for 1 a cell that can
More informationMeasurement of Hematopoietic Stem Cell Potency Prior to Transplantation
WHITE PAPER Measurement of Hematopoietic Stem Cell Potency Prior to Transplantation February, 2009 This White Paper is a forward-looking statement. It represents the present state of the art and future
More informationCell Processing at CAGT. Overview. Adrian P. Gee Center for Cell & Gene Therapy. CAGT Introduction
Cell Processing at CAGT Adrian P. Center for Cell & Gene Therapy CAGT Introduction Overview Facility Description Products prepared Flow cytometry Quality Control Quality Assurance 1 Center for Cell & Gene
More informationStem Cell Research and Kidney Disease
Stem Cell Research and Kidney Disease By Gordon Lore Stem cell research is one of the hottest, controversial, and ethical topics on the medical and political fronts. While research on adult stem cells
More informationFREQUENTLY ASKED QUESTIONSON STEM CELLS AND THEIR CLINICAL APPLICATIONS/THERAPY
FREQUENTLY ASKED QUESTIONSON STEM CELLS AND THEIR CLINICAL APPLICATIONS/THERAPY Basics of Stem Cells 1) What is a cell? Cell is the building block of our body. It is the smallest structural and functional
More informationStem Cells 101. Christopher Centeno, M.D. The Centeno-Schultz Clinic Colorado, USA
Stem Cells 101 Christopher Centeno, M.D. The Centeno-Schultz Clinic Colorado, USA My background Began using stem cells to treat orthopedic conditions in 2005 Have published 16 peer reviewed publications
More informationImmunotherapy in myeloma
Immunotherapy in myeloma This Horizons Infosheet contains information on immunotherapy, a type of treatment being investigated in myeloma. The Horizons Infosheet series provides information relating to
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES COMMISSION STAFF WORKING PAPER REPORT ON HUMAN EMBRYONIC STEM CELL RESEARCH
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 3.4.2003 SEC(2003) 441 COMMISSION STAFF WORKING PAPER REPORT ON HUMAN EMBRYONIC STEM CELL RESEARCH TABLE OF CONTENTS Executive summary...4 Introduction.
More informationTreatment strategies for relapsing and refractory myeloma
Treatment strategies for relapsing and refractory myeloma Dr Guy Pratt #MyelomaInfodays This talk will cover What is relapse and refractory myeloma Treatment options for relapse Treatment options for refractory
More informationDevelopment of non-substantially manipulated cell-based ATMPs 1 : flexibility introduced via the application of the risk-based approach
3 July 2017 EMA/CAT/216556/2017 Inspections, Human Medicines, Pharmacovigilance and Committees Division Development of non-substantially manipulated cell-based ATMPs 1 : flexibility introduced via the
More informationManufacturing Challenges with Cell and Gene Therapy Products: A Health Canada Perspective
Manufacturing Challenges with Cell and Gene Therapy Products: A Health Canada Perspective CASSS CMC Summer Forum 2017 Chris Storbeck, PhD Health Canada Outline Health Canada organization Regulation of
More information4000: Cellular Therapy Essential Data Pre- Infusion
4000: Cellular Therapy Essential Data Pre- Infusion! This form must be completed for all recipients of cellular therapy (non-hct) where it is the first indication for treatment (no prior hematopoietic
More informationThis talk will cover. Treatment for relapsed and/or refractory myeloma. What is relapsed myeloma and refractory myeloma. Treatment options for relapse
This talk will cover Treatment for relapsed and/or refractory myeloma Dr Guy Pratt Consultant Haematologist Heart of England NHS Trust and Senior Lecturer in Haematology University of Birmingham What is
More informationStem cell therapies in MS
Stem cell therapies in MS Produced in partnership between Contents Introduction 2 What is MS? 3 What are stem cells? 4 What is a stem cell therapy? 5 How could stem cells help in MS? 5 What types of stem
More informationDr Guy Pratt Consultant Haematologist, Heart of England NHS Foundation Trust. Natural course of myeloma. Some definitions. First relapse.
Outlook for myeloma patients has improved Treatment for relapsed and/or refractory myeloma Dr Guy Pratt Consultant Haematologist, Heart of England NHS Foundation Trust Senior Lecturer, University of Birmingham
More informationMedicyte GmbH. Infinity Gets Cultured. European Business Development Conference, Dresden October 2014 Björn F. Lindemann, CEO
Medicyte GmbH Infinity Gets Cultured European Business Development Conference, Dresden October 2014 Björn F. Lindemann, CEO Medicyte GmbH Founded 2007, privately owned Unique IP protected technology ISO
More informationHonors 177 MIDTERM. OncoProbe
Honors 177 MIDTERM OncoProbe Portable Cancer Diagnostic Tool On-the-Go Kathy T. Ngo Chemistry Major Physical Chemistry Concentration ABSTRACT Current advances in stem cell biology in the last two years
More informationAdipose rabbit mesenchymal stem cells for the treatment of the chronic scar tissue of the vocal cords
Adipose rabbit mesenchymal stem cells for the treatment of the chronic scar tissue of the vocal cords Dr. Vasiliki E Kalodimou, Head of Flow Cytometry-Research and Regenerative Medicine Department, IASO-Maternity
More informationRegulatory Updates on Cellular Therapy Products in Japan
Regulatory Updates on Cellular Therapy Products in Japan Daiju Okuda, Ph.D. Principle Reviewer Office of Cellular and Tissue-based Products Pharmaceuticals and Medical Devices Agency (PMDA), Japan September
More informationSTEM CELLS. An Interactive Qualifying Project Report. Submitted to the Faculty of WORCESTER POLYTECHNIC INSTITUTE
IQP-43-DSA-2840 IQP-43-DSA-7251 STEM CELLS An Interactive Qualifying Project Report Submitted to the Faculty of WORCESTER POLYTECHNIC INSTITUTE In partial fulfillment of the requirements for the Degree
More informationStem Cell Regenerative Therapy
Stem Cell Regenerative Therapy Standards & Guidelines January 2018 v1 Serving the public by guiding the medical profession Approval Date: November 30, 2017 Originating Committee: Advisory Committee on
More informationInvitation for Conference
Invitation for Conference Global Summit and Expo on Current Scenario and Future Stem Cell Medicine Website: http://stemcell.scientificsynergy.com/ Email id: contact@scientificsynergy.com stemcell@scientificsynergy.com
More information5.5. Multicellular Life. Multicellular organisms depend on interactions among different cell types.
5.5 Multicellular Life VOCABULARY tissue organ organ system cell differentiation stem cell Key Concept Cells work together to carry out complex functions. MAIN IDEAS Multicellular organisms depend on interactions
More informationMy PCR Frequently Asked Questions
My PCR Frequently Asked Questions Dear friend, This Frequently Asked Questions (FAQ) booklet has been created for you as part of the My PCR. The booklet contains FAQs prepared by chronic myeloid leukemia
More informationCell and Gene Therapy Catapult preclinical database
Cell and Gene Therapy Catapult preclinical database The UK Preclinical Database covers preclinical research activity concerning cell, gene and other advanced therapies that the Cell and Gene Therapy Catapult
More informationCloning For Embryonic Stem Cells
Cloning For Embryonic Stem Cells Defining the Terms Types of cloning - There are three types of cloning: (1) reproductive cloning, (2) therapeutic cloning and (3) recombinant DNA technology or gene cloning.
More informationBD MOSAIC h MSC CELL CULTURE ENVIRONMENT DEFINED SERUM FREE
BD MOSAIC h MSC CELL CULTURE ENVIRONMENT DEFINED SERUM FREE As the promise of stem cell therapy grows, so does the need for reliable tools for cell expansion in both research and clinical applications.
More informationAn Overview of Chimeric Antigen Receptor T-cells: CAR-T-ing Away Cancer
An Overview of Chimeric Antigen Receptor T-cells: CAR-T-ing Away Cancer Maxwell Brown, PharmD Clinical Pharmacy Manager, Hematopoietic Stem Cell Transplantation NewYork-Presbyterian/Weill Cornell Medical
More informationResearch Strategy Delivering internationally excellent research for a healthy, safe and sustainable society
Research Strategy 2016-2018 Delivering internationally excellent research for a healthy, safe and sustainable society Mission The College of Biomedical and Life Sciences aims to deliver internationally
More informationTreatment strategies for relapsing and refractory myeloma
Treatment strategies for relapsing and refractory myeloma Prof Gordon Cook Professor of Haematology and Myeloma Studies University of Leeds & Leeds Cancer Centre #MyelomaInfodays This talk will cover The
More informationNHS ENGLAND BOARD PAPER
NHS ENGLAND BOARD PAPER Paper: PB.30.03.2017/06 Title: Creating a genomic medicine service to lay the foundations to deliver personalised interventions and treatments Lead Director: Professor Sir Bruce
More information